Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lyla J Stanland

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Future Virology|August 9, 2021
Molecular features and translational outlook for Epstein-Barr virus-associated gastric cancerLyla J Stanland, Micah A Luftig
Viruses|October 31, 2020
The Role of EBV-Induced Hypermethylation in Gastric Cancer TumorigenesisLyla J Stanland, Micah A Luftig
STAR Protocols|January 9, 2026
Protocols to evaluate mutant specificity of an oncogene-targeting siRNA using orthogonal in vitro and in vivo approachesLyla J Stanland, Alessandro Porrello, Martin Egli, et al.
Mbio|July 4, 2019
Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency IIIJoshua E Messinger, Joanne Dai, Lyla J Stanland, et al.
Molecular Cancer Research : MCR|July 26, 2023
CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric CancerLyla J Stanland, Hazel X Ang, Jacob P Hoj, et al.
Cancer Cell|June 20, 2025
A first-in-class EGFR-directed KRAS G12V selective inhibitorLyla J Stanland, Hayden P Huggins, Snehasudha S Sahoo, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Future Virology|August 9, 2021
Molecular features and translational outlook for Epstein-Barr virus-associated gastric cancerLyla J Stanland, Micah A Luftig
Viruses|October 31, 2020
The Role of EBV-Induced Hypermethylation in Gastric Cancer TumorigenesisLyla J Stanland, Micah A Luftig
STAR Protocols|January 9, 2026
Protocols to evaluate mutant specificity of an oncogene-targeting siRNA using orthogonal in vitro and in vivo approachesLyla J Stanland, Alessandro Porrello, Martin Egli, et al.
Mbio|July 4, 2019
Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency IIIJoshua E Messinger, Joanne Dai, Lyla J Stanland, et al.
Molecular Cancer Research : MCR|July 26, 2023
CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric CancerLyla J Stanland, Hazel X Ang, Jacob P Hoj, et al.
Cancer Cell|June 20, 2025
A first-in-class EGFR-directed KRAS G12V selective inhibitorLyla J Stanland, Hayden P Huggins, Snehasudha S Sahoo, et al.
Pageof 1